Deoxysphingoid bases as plasma markers in Diabetes mellitus

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Bertea, Mariana ^a   Rütti, Markus F ^c   Othman, Alaa ^a   Marti Jaun, Jaqueline ^d   Hersberger, Martin ^d   Von Eckardstein, Arnold ^a   Hornemann, Thorsten ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Competence Center for Systems Physiology and Metabolic Diseases ^*  (Switzerland)

^c Hospital Wil   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; ALANINE; AMINO ACID; ANTILIPEMIC AGENT; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; PALMITOYL COENZYME A; SERINE; SERINE PALMITOYLTRANSFERASE; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; DRUG DERIVATIVE; LIPOPROTEIN;

ADULT; AMINO ACID METABOLISM; ARTICLE; CASE CONTROL STUDY; CATALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROLYSIS; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; PLASMA; RECEIVER OPERATING CHARACTERISTIC; SYNTHESIS; AGED; BLOOD; BODY MASS; CHEMISTRY; DIABETIC NEUROPATHY; DISEASE COURSE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; STATISTICS;

SPHINGOIDEA;

AGED; ALANINE; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; SERINE; SPHINGOLIPIDS; SPHINGOSINE; STATISTICS AS TOPIC;

EID: 77955526888     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-84     Document Type: Article

References (18)

1. Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase. T Hornemann S Richard MF Rutti Y Wei A von Eckardstein, J Biol Chem 2006 281 49 37275 37281 10.1074/jbc.M608066200 17023427
2. Is the mammalian serine palmitoyltransferase a high-molecular-mass complex? T Hornemann Y Wei A von Eckardstein, Biochem J 2007 405 1 157 164 17331073
3. The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. T Hornemann A Penno MF Rutti D Ernst F Kivrak-Pfiffner L Rohrer A von Eckardstein, J Biol Chem 2009 284 39 26322 26330 10.1074/jbc.M109.023192 19648650
4. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. A Penno MM Reilly H Houlden M Laura K Rentsch V Niederkofler ET Stoeckli G Nicholson F Eichler RH Brown Jr, et al. J Biol Chem 2010 285 15 11178 11187 10.1074/jbc.M109.092973 20097765
5. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxy-sphinganine: A novel category of bioactive 1-deoxy-sphingoid bases and 1-deoxy-dihydroceramides biosynthesized by mammalian cell lines and animals. NC Zitomer T Mitchell KA Voss GS Bondy ST Pruett EC Garnier-Amblard LS Liebeskind H Park E Wang MC Sullards, et al. J Biol Chem 2009 284 8 4786 4795 10.1074/jbc.M808798200 19095642
6. Overexpression of the wild-type SPT1 subunit lowers Desoxysphingolipid levels and rescues the phenotype of HSAN1. FS Eichler T Hornemann A McCampbell D Kuljis A Penno D Vardeh E Tamrazian K Garofalo HJ Lee L Kini, et al. J Neurosci 2009 29 46 14646 14651 10.1523/JNEUROSCI.2536-09.2009 19923297
7. The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway. M Salcedo C Cuevas JL Alonso G Otero G Faircloth JM Fernandez-Sousa J Avila F Wandosell, Apoptosis 2007 12 2 395 409 10.1007/s10495-006-0573-z 17191124
8. Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation. AM Sanchez S Malagarie-Cazenave N Olea D Vara C Cuevas I Diaz-Laviada, Eur J Pharmacol 2008 584 2-3 237 245 10.1016/j.ejphar.2008.02.011 18343365
9. The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers. R Cuadros E Montejo de Garcini F Wandosell G Faircloth JM Fernandez-Sousa J Avila, Cancer Lett 2000 152 1 23 29 10.1016/S0304-3835(99)00428-0 10754202
10. Hereditary sensory neuropathy type I. M Auer-Grumbach, Orphanet J Rare Dis 2008 3 7 10.1186/1750-1172-3-7 18348718
11. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxy-sphinganine: A novel category of bioactive 1-deoxy-sphingoid bases and 1-deoxy-dihydroceramides biosynthesized by mammalian cell lines and animals. NC Zitomer T Mitchell KA Voss GS Bondy ST Pruett EC Garnier-Amblard LS Liebeskind H Park E Wang MC Sullards, et al. J Biol Chem 2008 19095642
12. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity. K Gable SD Gupta G Han S Niranjanakumari JM Harmon TM Dunn, J Biol Chem 2010 285 30 22846 22852 10.1074/jbc.M110.122259 20504773
13. The c.-292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective. J Wittwer M Bayer A Mosandl J Muntwyler M Hersberger, Clin Chem Lab Med 2007 45 4 487 492 10.1515/CCLM.2007.103 17439326
14. Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor. JL Kelley AW Kruski, Methods Enzymol 1986 128 170 181 full-text 3724501
15. Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids. MP Frank RW Powers, J Chromatogr B Analyt Technol Biomed Life Sci 2007 852 1-2 646 649 10.1016/j.jchromb.2007.01.002 17254851
16. Splanchnic glucose and amino acid metabolism in obesity. P Felig J Wahren R Hendler T Brundin, J Clin Invest 1974 53 2 582 590 10.1172/JCI107593 11344573
17. Update on the pathogenesis of diabetic neuropathy. IG Obrosova, Curr Diab Rep 2003 3 6 439 445 10.1007/s11892-003-0005-1 14611738
18. Update on diabetic neuropathy. Z Simmons EL Feldman, Curr Opin Neurol 2002 15 5 595 603 10.1097/00019052-200210000-00010 12352003